APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bictegravir

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Bictegravir Industry Growth and Trends Forecast to 2032

29 December 2025104 pages

Choose your research edition.

Industry ResearchBictegravir Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Bictegravir Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Bictegravir Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bictegravir Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Bictegravir Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Bictegravir market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Bictegravir is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Bictegravir is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bictegravir is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Bictegravir include Cipla, Gilead Sciences, Hetero Drugs Limited, Laurus Labs, Selleck Chemicals, Changzhou Pharmaceutical Factory, Jiangsu Coben Pharmaceutical, Shanghai Desano Chemical PharmaceuticalShanghai Desano Chemical Pharmaceutical and Shanghai Haoyuan Chemexpress, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Bictegravir market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Bictegravir market size, estimates, and forecasts are presented in terms of sales volume (Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Bictegravir market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Bictegravir.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Bictegravir market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Bictegravir Market by Company

Cipla

Gilead Sciences

Hetero Drugs Limited

Laurus Labs

Selleck Chemicals

Changzhou Pharmaceutical Factory

Jiangsu Coben Pharmaceutical

Shanghai Desano Chemical PharmaceuticalShanghai Desano Chemical Pharmaceutical

Shanghai Haoyuan Chemexpress

Shanghai Systeam Biochem

Shanghai Topscience

ShenZhen HwaGen Pharmaceutical

Bictegravir Segment by Type

97% - 99%

Above 99%

Bictegravir Segment by Application

Hospitals

Clinics

Labs

Bictegravir Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bictegravir market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bictegravir and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bictegravir.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Bictegravir manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Bictegravir in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 97% - 99% Table 2. Major Company of Above 99% Table 3. Global Bictegravir Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Bictegravir Sales by Type (2021-2026) & (Tons) Table 5. Global Bictegravir Sales Market Share in Volume by Type (2021-2026) Table 6. Global Bictegravir Sales by Type (2021-2026) & (US$ Million) Table 7. Global Bictegravir Sales Market Share in Value by Type (2021-2026) Table 8. Global Bictegravir Price by Type (2021-2026) & (US$/Ton) Table 9. Global Bictegravir Sales by Type (2027-2032) & (Tons) Table 10. Global Bictegravir Sales Market Share in Volume by Type (2027-2032) Table 11. Global Bictegravir Sales by Type (2027-2032) & (US$ Million) Table 12. Global Bictegravir Sales Market Share in Value by Type (2027-2032) Table 13. Global Bictegravir Price by Type (2027-2032) & (US$/Ton) Table 14. North America Bictegravir Sales by Type (2021-2026) & (Tons) Table 15. North America Bictegravir Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Bictegravir Sales by Type (2021-2026) & (Tons) Table 17. Europe Bictegravir Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Bictegravir Sales by Type (2021-2026) & (Tons) Table 19. Asia-Pacific Bictegravir Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Bictegravir Sales by Type (2021-2026) & (Tons) Table 21. Latin America Bictegravir Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Bictegravir Sales by Type (2021-2026) & (Tons) Table 23. Middle East and Africa Bictegravir Sales by Type (2021-2026) & (US$ Million) Table 24. Bictegravir Industry Trends Table 25. Bictegravir Industry Drivers Table 26. Bictegravir Industry Opportunities and Challenges Table 27. Bictegravir Industry Restraints Table 28. Global Bictegravir Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Bictegravir Revenue Market Share by Company (2021-2026) Table 30. Global Bictegravir Sales by Company (2021-2026) & (Tons) Table 31. Global Bictegravir Sales Share by Company (2021-2026) Table 32. Global Bictegravir Market Price by Company (2021-2026) & (US$/Ton) Table 33. Global Bictegravir Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Bictegravir Major Company Production Sites and Headquarters Table 35. Global Bictegravir Company, Product Type & Application Table 36. Global Bictegravir Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Bictegravir by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Bictegravir Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Bictegravir Sales by Region (2021-2026) & (Tons) Table 41. Global Bictegravir Sales Market Share in Volume by Region (2021-2026) Table 42. Global Bictegravir Sales by Region (2021-2026) & (US$ Million) Table 43. Global Bictegravir Sales Market Share in Value by Region (2021-2026) Table 44. Global Bictegravir Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 45. Global Bictegravir Sales by Region (2027-2032) & (Tons) Table 46. Global Bictegravir Sales Market Share in Volume by Region (2027-2032) Table 47. Global Bictegravir Sales by Region (2027-2032) & (US$ Million) Table 48. Global Bictegravir Sales Market Share in Value by Region (2027-2032) Table 49. Global Bictegravir Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2027-2032) Table 50. Global Bictegravir Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Bictegravir Sales by Application (2021-2026) & (Tons) Table 52. Global Bictegravir Sales Market Share in Volume by Application (2021-2026) Table 53. Global Bictegravir Sales by Application (2021-2026) & (US$ Million) Table 54. Global Bictegravir Sales Market Share in Value by Application (2021-2026) Table 55. Global Bictegravir Price by Application (2021-2026) & (US$/Ton) Table 56. Global Bictegravir Sales by Application (2027-2032) & (Tons) Table 57. Global Bictegravir Sales Market Share in Volume by Application (2027-2032) Table 58. Global Bictegravir Sales by Application (2027-2032) & (US$ Million) Table 59. Global Bictegravir Sales Market Share in Value by Application (2027-2032) Table 60. Global Bictegravir Price by Application (2027-2032) & (US$/Ton) Table 61. North America Bictegravir Sales by Application (2021-2026) & (Tons) Table 62. North America Bictegravir Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Bictegravir Sales by Application (2021-2026) & (Tons) Table 64. Europe Bictegravir Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Bictegravir Sales by Application (2021-2026) & (Tons) Table 66. Asia-Pacific Bictegravir Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Bictegravir Sales by Application (2021-2026) & (Tons) Table 68. Latin America Bictegravir Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Bictegravir Sales by Application (2021-2026) & (Tons) Table 70. Middle East and Africa Bictegravir Sales by Application (2021-2026) & (US$ Million) Table 71. Cipla Company Information Table 72. Cipla Business Overview Table 73. Cipla Bictegravir Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 74. Cipla Bictegravir Product Portfolio Table 75. Cipla Recent Development Table 76. Gilead Sciences Company Information Table 77. Gilead Sciences Business Overview Table 78. Gilead Sciences Bictegravir Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 79. Gilead Sciences Bictegravir Product Portfolio Table 80. Gilead Sciences Recent Development Table 81. Hetero Drugs Limited Company Information Table 82. Hetero Drugs Limited Business Overview Table 83. Hetero Drugs Limited Bictegravir Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 84. Hetero Drugs Limited Bictegravir Product Portfolio Table 85. Hetero Drugs Limited Recent Development Table 86. Laurus Labs Company Information Table 87. Laurus Labs Business Overview Table 88. Laurus Labs Bictegravir Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 89. Laurus Labs Bictegravir Product Portfolio Table 90. Laurus Labs Recent Development Table 91. Selleck Chemicals Company Information Table 92. Selleck Chemicals Business Overview Table 93. Selleck Chemicals Bictegravir Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 94. Selleck Chemicals Bictegravir Product Portfolio Table 95. Selleck Chemicals Recent Development Table 96. Changzhou Pharmaceutical Factory Company Information Table 97. Changzhou Pharmaceutical Factory Business Overview Table 98. Changzhou Pharmaceutical Factory Bictegravir Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 99. Changzhou Pharmaceutical Factory Bictegravir Product Portfolio Table 100. Changzhou Pharmaceutical Factory Recent Development Table 101. Jiangsu Coben Pharmaceutical Company Information Table 102. Jiangsu Coben Pharmaceutical Business Overview Table 103. Jiangsu Coben Pharmaceutical Bictegravir Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 104. Jiangsu Coben Pharmaceutical Bictegravir Product Portfolio Table 105. Jiangsu Coben Pharmaceutical Recent Development Table 106. Shanghai Desano Chemical PharmaceuticalShanghai Desano Chemical Pharmaceutical Company Information Table 107. Shanghai Desano Chemical PharmaceuticalShanghai Desano Chemical Pharmaceutical Business Overview Table 108. Shanghai Desano Chemical PharmaceuticalShanghai Desano Chemical Pharmaceutical Bictegravir Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 109. Shanghai Desano Chemical PharmaceuticalShanghai Desano Chemical Pharmaceutical Bictegravir Product Portfolio Table 110. Shanghai Desano Chemical PharmaceuticalShanghai Desano Chemical Pharmaceutical Recent Development Table 111. Shanghai Haoyuan Chemexpress Company Information Table 112. Shanghai Haoyuan Chemexpress Business Overview Table 113. Shanghai Haoyuan Chemexpress Bictegravir Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 114. Shanghai Haoyuan Chemexpress Bictegravir Product Portfolio Table 115. Shanghai Haoyuan Chemexpress Recent Development Table 116. Shanghai Systeam Biochem Company Information Table 117. Shanghai Systeam Biochem Business Overview Table 118. Shanghai Systeam Biochem Bictegravir Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 119. Shanghai Systeam Biochem Bictegravir Product Portfolio Table 120. Shanghai Systeam Biochem Recent Development Table 121. Shanghai Topscience Company Information Table 122. Shanghai Topscience Business Overview Table 123. Shanghai Topscience Bictegravir Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 124. Shanghai Topscience Bictegravir Product Portfolio Table 125. Shanghai Topscience Recent Development Table 126. ShenZhen HwaGen Pharmaceutical Company Information Table 127. ShenZhen HwaGen Pharmaceutical Business Overview Table 128. ShenZhen HwaGen Pharmaceutical Bictegravir Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 129. ShenZhen HwaGen Pharmaceutical Bictegravir Product Portfolio Table 130. ShenZhen HwaGen Pharmaceutical Recent Development Table 131. North America Bictegravir Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 132. North America Bictegravir Sales by Country (2021-2026) & (Tons) Table 133. North America Bictegravir Sales Market Share by Country (2021-2026) Table 134. North America Bictegravir Sales Forecast by Country (2027-2032) & (Tons) Table 135. North America Bictegravir Sales Market Share Forecast by Country (2027-2032) Table 136. North America Bictegravir Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. North America Bictegravir Market Size by Country (2021-2026) & (US$ Million) Table 138. North America Bictegravir Market Share by Country (2021-2026) Table 139. North America Bictegravir Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. North America Bictegravir Market Share Forecast by Country (2027-2032) Table 141. Europe Bictegravir Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 142. Europe Bictegravir Sales by Country (2021-2026) & (Tons) Table 143. Europe Bictegravir Sales Market Share by Country (2021-2026) Table 144. Europe Bictegravir Sales Forecast by Country (2027-2032) & (Tons) Table 145. Europe Bictegravir Sales Market Share Forecast by Country (2027-2032) Table 146. Europe Bictegravir Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Europe Bictegravir Market Size by Country (2021-2026) & (US$ Million) Table 148. Europe Bictegravir Market Share by Country (2021-2026) Table 149. Europe Bictegravir Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Europe Bictegravir Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Bictegravir Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Bictegravir Sales by Country (2021-2026) & (Tons) Table 153. Asia-Pacific Bictegravir Sales Market Share by Country (2021-2026) Table 154. Asia-Pacific Bictegravir Sales Forecast by Country (2027-2032) & (Tons) Table 155. Asia-Pacific Bictegravir Sales Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Bictegravir Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Bictegravir Market Size by Country (2021-2026) & (US$ Million) Table 158. Asia-Pacific Bictegravir Market Share by Country (2021-2026) Table 159. Asia-Pacific Bictegravir Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Asia-Pacific Bictegravir Market Share Forecast by Country (2027-2032) Table 161. Latin America Bictegravir Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 162. Latin America Bictegravir Sales by Country (2021-2026) & (Tons) Table 163. Latin America Bictegravir Sales Market Share by Country (2021-2026) Table 164. Latin America Bictegravir Sales Forecast by Country (2027-2032) & (Tons) Table 165. Latin America Bictegravir Sales Market Share Forecast by Country (2027-2032) Table 166. Latin America Bictegravir Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Latin America Bictegravir Market Size by Country (2021-2026) & (US$ Million) Table 168. Latin America Bictegravir Market Share by Country (2021-2026) Table 169. Latin America Bictegravir Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Latin America Bictegravir Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Bictegravir Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Bictegravir Sales by Country (2021-2026) & (Tons) Table 173. Middle East and Africa Bictegravir Sales Market Share by Country (2021-2026) Table 174. Middle East and Africa Bictegravir Sales Forecast by Country (2027-2032) & (Tons) Table 175. Middle East and Africa Bictegravir Sales Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Bictegravir Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Bictegravir Market Size by Country (2021-2026) & (US$ Million) Table 178. Middle East and Africa Bictegravir Market Share by Country (2021-2026) Table 179. Middle East and Africa Bictegravir Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Middle East and Africa Bictegravir Market Share Forecast by Country (2027-2032) Table 181. Key Raw Materials Table 182. Raw Materials Key Suppliers Table 183. Bictegravir Distributors List Table 184. Bictegravir Customers List Table 185. Research Programs/Design for This Report Table 186. Authors List of This Report Table 187. Secondary Sources Table 188. Primary Sources List of Figures Figure 1. Bictegravir Image Figure 2. Global Bictegravir Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bictegravir Market Size (2021-2032) & (US$ Million) Figure 4. Global Bictegravir Sales (2021-2032) & (Tons) Figure 5. 97% - 99% Image Figure 6. Global 97% - 99% Sales YoY Growth (2021-2032) & (Tons) Figure 7. Above 99% Image Figure 8. Global Above 99% Sales YoY Growth (2021-2032) & (Tons) Figure 9. Global Bictegravir Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Bictegravir Market Share by Type 2025 VS 2032 Figure 11. North America Bictegravir Sales Market Share in Volume by Type in 2025 Figure 12. North America Bictegravir Sales Market Share in Value by Type in 2025 Figure 13. Europe Bictegravir Sales Market Share in Volume by Type in 2025 Figure 14. Europe Bictegravir Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Bictegravir Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Bictegravir Sales Market Share in Value by Type in 2025 Figure 17. Latin America Bictegravir Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Bictegravir Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Bictegravir Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Bictegravir Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Bictegravir Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospitals Image Figure 24. Global Hospitals Sales YoY Growth (2021-2032) & (Tons) Figure 25. Clinics Image Figure 26. Global Clinics Sales YoY Growth (2021-2032) & (Tons) Figure 27. Labs Image Figure 28. Global Labs Sales YoY Growth (2021-2032) & (Tons) Figure 29. Global Bictegravir Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Bictegravir Market Share by Application 2025 VS 2032 Figure 31. North America Bictegravir Sales Market Share in Volume by Application in 2025 Figure 32. North America Bictegravir Sales Market Share in Value by Application in 2025 Figure 33. Europe Bictegravir Sales Market Share in Volume by Application in 2025 Figure 34. Europe Bictegravir Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Bictegravir Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Bictegravir Sales Market Share in Value by Application in 2025 Figure 37. Latin America Bictegravir Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Bictegravir Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Bictegravir Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Bictegravir Sales Market Share in Value by Application in 2025 Figure 41. North America Bictegravir Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 42. North America Bictegravir Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Bictegravir Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Bictegravir Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Bictegravir Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 46. Europe Bictegravir Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Bictegravir Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Bictegravir Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Bictegravir Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 50. Asia-Pacific Bictegravir Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Bictegravir Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Bictegravir Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Bictegravir Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 54. Latin America Bictegravir Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Bictegravir Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Bictegravir Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Bictegravir Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 58. Middle East and Africa Bictegravir Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Bictegravir Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Bictegravir Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Bictegravir Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Bictegravir Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 97% - 99%
  • Above 99%
Applications
  • Hospitals
  • Clinics
  • Labs
Companies covered
  • Cipla
  • Gilead Sciences
  • Hetero Drugs Limited
  • Laurus Labs
  • Selleck Chemicals
  • Changzhou Pharmaceutical Factory
  • Jiangsu Coben Pharmaceutical
  • Shanghai Desano Chemical PharmaceuticalShanghai Desano Chemical Pharmaceutical
  • Shanghai Haoyuan Chemexpress
  • Shanghai Systeam Biochem
  • Shanghai Topscience
  • ShenZhen HwaGen Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Bictegravir Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Bictegravir Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Bictegravir Market by Type
  6. 1.3.1 97% - 99%
  7. 1.3.2 Above 99%
  8. 1.4 Global Bictegravir Market Size by Type
  9. 1.4.1 Global Bictegravir Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Bictegravir Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Bictegravir Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Bictegravir Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Bictegravir Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Bictegravir Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Bictegravir Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Bictegravir Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Bictegravir Industry Trends
  2. 2.2 Bictegravir Industry Drivers
  3. 2.3 Bictegravir Industry Opportunities and Challenges
  4. 2.4 Bictegravir Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Bictegravir Revenue (2021-2026)
  2. 3.2 Global Top Players by Bictegravir Sales (2021-2026)
  3. 3.3 Global Top Players by Bictegravir Price (2021-2026)
  4. 3.4 Global Bictegravir Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Bictegravir Major Company Production Sites & Headquarters
  6. 3.6 Global Bictegravir Company, Product Type & Application
  7. 3.7 Global Bictegravir Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Bictegravir Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Bictegravir Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Bictegravir Tier 1, Tier 2, and Tier 3
4 Bictegravir Regional Status and Outlook
  1. 4.1 Global Bictegravir Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Bictegravir Historic Market Size by Region
  3. 4.2.1 Global Bictegravir Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Bictegravir Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Bictegravir Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Bictegravir Forecasted Market Size by Region
  7. 4.3.1 Global Bictegravir Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Bictegravir Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Bictegravir Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Bictegravir by Application
  1. 5.1 Bictegravir Market by Application
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Labs
  5. 5.2 Global Bictegravir Market Size by Application
  6. 5.2.1 Global Bictegravir Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Bictegravir Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Bictegravir Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Bictegravir Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Bictegravir Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Bictegravir Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Bictegravir Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Bictegravir Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Cipla
  2. 6.1.1 Cipla Company Information
  3. 6.1.2 Cipla Business Overview
  4. 6.1.3 Cipla Bictegravir Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Cipla Bictegravir Product Portfolio
  6. 6.1.5 Cipla Recent Developments
  7. 6.2 Gilead Sciences
  8. 6.2.1 Gilead Sciences Company Information
  9. 6.2.2 Gilead Sciences Business Overview
  10. 6.2.3 Gilead Sciences Bictegravir Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Gilead Sciences Bictegravir Product Portfolio
  12. 6.2.5 Gilead Sciences Recent Developments
  13. 6.3 Hetero Drugs Limited
  14. 6.3.1 Hetero Drugs Limited Company Information
  15. 6.3.2 Hetero Drugs Limited Business Overview
  16. 6.3.3 Hetero Drugs Limited Bictegravir Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Hetero Drugs Limited Bictegravir Product Portfolio
  18. 6.3.5 Hetero Drugs Limited Recent Developments
  19. 6.4 Laurus Labs
  20. 6.4.1 Laurus Labs Company Information
  21. 6.4.2 Laurus Labs Business Overview
  22. 6.4.3 Laurus Labs Bictegravir Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Laurus Labs Bictegravir Product Portfolio
  24. 6.4.5 Laurus Labs Recent Developments
  25. 6.5 Selleck Chemicals
  26. 6.5.1 Selleck Chemicals Company Information
  27. 6.5.2 Selleck Chemicals Business Overview
  28. 6.5.3 Selleck Chemicals Bictegravir Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Selleck Chemicals Bictegravir Product Portfolio
  30. 6.5.5 Selleck Chemicals Recent Developments
  31. 6.6 Changzhou Pharmaceutical Factory
  32. 6.6.1 Changzhou Pharmaceutical Factory Company Information
  33. 6.6.2 Changzhou Pharmaceutical Factory Business Overview
  34. 6.6.3 Changzhou Pharmaceutical Factory Bictegravir Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Changzhou Pharmaceutical Factory Bictegravir Product Portfolio
  36. 6.6.5 Changzhou Pharmaceutical Factory Recent Developments
  37. 6.7 Jiangsu Coben Pharmaceutical
  38. 6.7.1 Jiangsu Coben Pharmaceutical Company Information
  39. 6.7.2 Jiangsu Coben Pharmaceutical Business Overview
  40. 6.7.3 Jiangsu Coben Pharmaceutical Bictegravir Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Jiangsu Coben Pharmaceutical Bictegravir Product Portfolio
  42. 6.7.5 Jiangsu Coben Pharmaceutical Recent Developments
  43. 6.8 Shanghai Desano Chemical PharmaceuticalShanghai Desano Chemical Pharmaceutical
  44. 6.8.1 Shanghai Desano Chemical PharmaceuticalShanghai Desano Chemical Pharmaceutical Company Information
  45. 6.8.2 Shanghai Desano Chemical PharmaceuticalShanghai Desano Chemical Pharmaceutical Business Overview
  46. 6.8.3 Shanghai Desano Chemical PharmaceuticalShanghai Desano Chemical Pharmaceutical Bictegravir Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Shanghai Desano Chemical PharmaceuticalShanghai Desano Chemical Pharmaceutical Bictegravir Product Portfolio
  48. 6.8.5 Shanghai Desano Chemical PharmaceuticalShanghai Desano Chemical Pharmaceutical Recent Developments
  49. 6.9 Shanghai Haoyuan Chemexpress
  50. 6.9.1 Shanghai Haoyuan Chemexpress Company Information
  51. 6.9.2 Shanghai Haoyuan Chemexpress Business Overview
  52. 6.9.3 Shanghai Haoyuan Chemexpress Bictegravir Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Shanghai Haoyuan Chemexpress Bictegravir Product Portfolio
  54. 6.9.5 Shanghai Haoyuan Chemexpress Recent Developments
  55. 6.10 Shanghai Systeam Biochem
  56. 6.10.1 Shanghai Systeam Biochem Company Information
  57. 6.10.2 Shanghai Systeam Biochem Business Overview
  58. 6.10.3 Shanghai Systeam Biochem Bictegravir Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Shanghai Systeam Biochem Bictegravir Product Portfolio
  60. 6.10.5 Shanghai Systeam Biochem Recent Developments
  61. 6.11 Shanghai Topscience
  62. 6.11.1 Shanghai Topscience Company Information
  63. 6.11.2 Shanghai Topscience Business Overview
  64. 6.11.3 Shanghai Topscience Bictegravir Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Shanghai Topscience Bictegravir Product Portfolio
  66. 6.11.5 Shanghai Topscience Recent Developments
  67. 6.12 ShenZhen HwaGen Pharmaceutical
  68. 6.12.1 ShenZhen HwaGen Pharmaceutical Company Information
  69. 6.12.2 ShenZhen HwaGen Pharmaceutical Business Overview
  70. 6.12.3 ShenZhen HwaGen Pharmaceutical Bictegravir Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 ShenZhen HwaGen Pharmaceutical Bictegravir Product Portfolio
  72. 6.12.5 ShenZhen HwaGen Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Bictegravir Sales by Country
  2. 7.1.1 North America Bictegravir Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Bictegravir Sales by Country (2021-2026)
  4. 7.1.3 North America Bictegravir Sales Forecast by Country (2027-2032)
  5. 7.2 North America Bictegravir Market Size by Country
  6. 7.2.1 North America Bictegravir Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Bictegravir Market Size by Country (2021-2026)
  8. 7.2.3 North America Bictegravir Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Bictegravir Sales by Country
  2. 8.1.1 Europe Bictegravir Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Bictegravir Sales by Country (2021-2026)
  4. 8.1.3 Europe Bictegravir Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Bictegravir Market Size by Country
  6. 8.2.1 Europe Bictegravir Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Bictegravir Market Size by Country (2021-2026)
  8. 8.2.3 Europe Bictegravir Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Bictegravir Sales by Country
  2. 9.1.1 Asia-Pacific Bictegravir Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Bictegravir Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Bictegravir Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Bictegravir Market Size by Country
  6. 9.2.1 Asia-Pacific Bictegravir Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Bictegravir Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Bictegravir Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Bictegravir Sales by Country
  2. 10.1.1 South America Bictegravir Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Bictegravir Sales by Country (2021-2026)
  4. 10.1.3 South America Bictegravir Sales Forecast by Country (2027-2032)
  5. 10.2 South America Bictegravir Market Size by Country
  6. 10.2.1 South America Bictegravir Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Bictegravir Market Size by Country (2021-2026)
  8. 10.2.3 South America Bictegravir Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Bictegravir Sales by Country
  2. 11.1.1 Middle East and Africa Bictegravir Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Bictegravir Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Bictegravir Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Bictegravir Market Size by Country
  6. 11.2.1 Middle East and Africa Bictegravir Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Bictegravir Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Bictegravir Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Bictegravir Value Chain Analysis
  2. 12.1.1 Bictegravir Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Bictegravir Production Mode & Process
  7. 12.2 Bictegravir Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Bictegravir Distributors
  10. 12.2.3 Bictegravir Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst